Intuitive Surgical, Inc. (ISRG)
Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning?
Intuitive Surgical was an early leader in the surgical robotics space. The industry has developed, and now the company faces material competition from well-heeled competitors.
Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?
Intuitive Surgical is boosting R&D despite macro headwinds, targeting AI, robotics and new procedures to expand its market and drive long-term growth.
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $372.6, indicating a +1.51% shift from the previous trading day.
Intuitive Surgical's Record Cash Flow Gives It an Innovation Advantage
ISRG's record cash flow is fueling R&D, manufacturing expansion and over 100 da Vinci 5 updates, strengthening its innovation edge.
Wall Street Bulls Look Optimistic About Intuitive Surgical (ISRG): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific
ISRG is expanding in Asia Pacific with a new Penang plant to boost capacity and support rising demand for robotic-assisted surgery.
Is ISRG's Software Strategy Becoming as Important as Its Robots?
ISRG's software roadmap is strengthening da Vinci 5, with new features, renewals and recurring service revenues reinforcing its digital ecosystem.
ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?
ISRG's US procedure growth slows in Q2, but ACA-related care deferrals may prove temporary as underlying demand and da Vinci 5 adoption remain strong.
Intuitive Surgical: Priced For Precision
Intuitive Surgical is rated a Hold, with a modeled +9.17% upside and a price target of $426.65. ISRG's growth thesis centers on untapped ASC procedure volume, overstated remanufacturing risks, and remanufacturing's role in expanding the installed base. Remanufacturing currently poses a limited threat, with sub-3% penetration and approval for only 4 out of 45+ instruments.
The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run
I keep hitting the buy button on Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction), and the recent drawdown has only made me press it harder.
ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now?
ISRG's premium valuation faces scrutiny as strong Q2 growth, higher margins and expanding robotic platforms support its 2026 outlook.
The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%
Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) trades at $373.71, while the average Wall Street price target sits at $477.25.
